GRPH - Graphite Bio, Inc.

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
0
0
0
0
0
Operating expenses
Research development
72,787
72,787
37,932
9,123
0
Selling general and administrative
32,852
32,852
22,511
4,377
29
Total operating expenses
105,639
105,639
60,443
13,500
29
Operating income or loss
-105,639
-105,639
-60,443
-13,500
-29
Interest expense
-
-
0
40
80
Total other income/expenses net
-
-
-10,317
-54,833
-
Income before tax
-101,052
-101,052
-70,760
-68,373
-109
Income from continuing operations
-101,052
-101,052
-70,760
-68,373
-109
Net income
-101,052
-101,052
-70,760
-68,373
-109
Net income available to common shareholders
-101,052
-101,052
-70,760
-13,540
-109
Basic EPS
-
-
-2.45
-2.00
-0.01
Diluted EPS
-
-
-2.45
-2.00
-0.01
Basic average shares
-
-
28,919
34,187
14,628
Diluted average shares
-
-
28,919
34,187
14,628
EBITDA
-
-105,639
-70,760
-68,212
-29